Are we equalizing health?
We let the numbers do the talking.
Letter from the Equalize Health Board of Directors
November 29, 2022
With great sorrow, we share the news that Equalize Health is closing its doors. This magnificent organization, which has done so much good in the world, came up against a cash timing issue which will not allow us to carry our work forward. It is not for want of trying. Equalize Health has faithful and generous donors, a committed, talented team, longtime advisors and partners, and a dedicated community. We are deeply saddened by what the loss of Equalize Health means to patients, to our employees, and to the world of global health.
While Equalize Health may be closing, we are so proud and humbled by the work that has been accomplished and the lasting footprint that has been left. Over 1.6M patients have been treated with Equalize Health medical devices. Our products have helped increase maternal and infant survival rates, improved mobility, and have scaled world-class, affordable solutions across 80 countries. 4,800 healthcare workers have been trained by Equalize Health’s ECHO Tele-mentoring Program.
Over time, Equalize Health has shown the global health community what it means to apply user-centered design to create products that really work for people in different environments, at a price that creates real market solutions. Our fervent hope is that others will pick up the mantle of this approach to carry forward the importance of making affordable and world-class medical devices available in every setting to individuals across the globe. We will also work to make sure that the organization’s products and IP find a useful home.
All of us who have supported and followed Equalize Health over its lifetime understand that innovation carries risk. Equalize Health has continually pushed the boundaries of innovation in the global health arena, in its fidelity to a user-centered design approach, in its focus on rigorous impact measurement and in the products it has put out into the world.
We feel an enormous appreciation to all our staff, collaborators, advisors - and to you, our community - for traveling a long and productive journey with us at Equalize Health. We are forever grateful for your support.
Equalize Health’s Board of Directors
We believe in a world where we all have access to world-class medical treatment, no matter where we live. Millions of people suffer and die from preventable or treatable conditions. Equalize Health is a not-for-profit medical technology company on a mission to change that. Here is how.
We identify the biggest gaps and opportunities in health care where tech can do the most good.
We design affordable, world-class medical products that work in the toughest circumstances.
We build global partnerships to ensure our products get to those who need them most.
A partnership to develop and launch a mother-centered, “blood loss monitoring device” to detect PPH, the leading cause of maternal death globally.
We offer our admiration and heartfelt thanks to Krista Donaldson, as she steps down from her role as CEO of Equalize Health. I represent Equalize Health’s Board of Directors when I say, we are grateful for Krista’s visionary leadership that has brought significant change to the lives of more than one million patients around the world.
After 13 years of leading this amazing organization from its early days in “the dark basement” (it wasn’t really) of an old house in Palo Alto to our multi-continent thriving organization that we are today, it is time for me to make room for a new CEO with diverse and fresh ideas.
The $15M Catalytic Fund will provide healthcare and world-class medical technologies to five million patients by 2025 and help end the leading causes of preventable maternal and newborn deaths.
Equalize Health CEO, Krista Donaldson, is a 2021 Elevate Prize winner.